Skip to main content

Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03)

National Institutes of Health

open
Rolling / OpenLast verified: 2026-07-05

About This Grant

The Division of Digestive Diseases and Nutrition (DDDN) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Division of Cancer Prevention of the National Cancer Institute encourage innovative clinical and epidemiological research into the role of Endoscopic Retrograde Cholangiopancreatography (ERCP) and other endoscopic and imaging techniques. Acute and chronic pancreatic and biliary diseases are common in the United States and account for considerable morbidity, mortality and health care costs. The spectrum of conditions includes those due to cancer of the exocrine and endocrine pancreas, gallstones, sludge, pancreatic and biliary malignancy, trauma, anatomic problems (pancreas divisum), alcohol and drugs and idiopathic syndromes such as idiopathic pancreatitis and sphincter of Oddi dysfunction. The recently held National Institutes of Health State-of-the-Science Conference Statement on ERCP indicated that while ERCP and other advanced endoscopic and imaging techniques have gained widespread application in clinical practice, there is little evidence based on rigorous clinical trials to guide the use of advanced diagnostic and therapeutic technologies in clinical practice decisions. The small grants (R03) may be used as planning grants for full-scale multi-center clinical trials or for pilot studies that could lead to full-scale multi-center clinical trials designed to provide evidence for or against changes in the current standard of care. Pilot epidemiological studies are encouraged that could lead to more extended research that would provide evidence for or against changes in health policy, especially as related to disease and cancer prevention. It is expected that these R03 grants will serve as a basis for planning future multi-center research project grant applications (R01) or cooperative agreement (U01) awards. New and experienced investigators in relevant fields and disciplines may apply for these small grants. Investigators are encouraged to take advantage of recent endoscopic and laboratory developments. In addition, the small grant is a good mechanism for new and experienced investigators to become better equipped to perform clinical and epidemiological research.

Grant Summary

Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03) is a National Institutes of Health grant providing up to $50K for municipality. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.

Focus Areas

education

Eligibility

municipality

How to Apply

Funding Range

Up to $50K

Deadline

Rolling / Open

Complexity
Medium
  1. 1Confirm your organization is eligible for Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03) from National Institutes of Health, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Start Application

Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.

Don't want to draft it yourself?

We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03): Frequently Asked Questions

Who is eligible for the Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03)?

Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03) is offered by National Institutes of Health and is generally open to municipality. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03) provide?

Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03) provides up to $50K per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03) deadline?

Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03) accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, National Institutes of Health, before you apply, and submit as early as possible because rolling programs can close once funds are committed.

How do you apply for the Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03)?

To apply for Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.

Browse More Grants